These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24766)

  • 21. Locomotor activity and speed of movements in relation to monoamine-acting drugs.
    Hassler R; Wagner A
    Int J Neurol; 1975; 10(1-4):80-97. PubMed ID: 126971
    [No Abstract]   [Full Text] [Related]  

  • 22. Neurosteroid and neurotransmitter alterations in Parkinson's disease.
    di Michele F; Luchetti S; Bernardi G; Romeo E; Longone P
    Front Neuroendocrinol; 2013 Apr; 34(2):132-42. PubMed ID: 23563222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The basal ganglia in extrapyramidal dysfunction.
    Barnes CD
    Brain Res Bull; 1983 Aug; 11(2):271-5. PubMed ID: 6226339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationships of aging changes in the basal ganglia to manifestations of Huntington's chorea.
    Finch CE
    Ann Neurol; 1980 May; 7(5):406-11. PubMed ID: 6446874
    [No Abstract]   [Full Text] [Related]  

  • 25. Cocaine-induced stereotypy is linked to an imbalance between the medial prefrontal and sensorimotor circuits of the basal ganglia.
    Aliane V; Pérez S; Nieoullon A; Deniau JM; Kemel ML
    Eur J Neurosci; 2009 Oct; 30(7):1269-79. PubMed ID: 19769590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GABA in the striatonigral and striatopallidal systems as moderator and mediator of striatal functions.
    Scheel-Krüger J
    Adv Neurol; 1984; 40():85-90. PubMed ID: 6141713
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of the subthalamic nucleus in the pathophysiology of Parkinson's disease.
    Blandini F
    Funct Neurol; 2001; 16(4 Suppl):99-106. PubMed ID: 11996537
    [No Abstract]   [Full Text] [Related]  

  • 28. [Basal ganglia disease. Functional neuroanatomy and therapeutic perspectives].
    Ostergaard K; Sunde NA; Dupont E
    Ugeskr Laeger; 2000 Oct; 162(41):5480-3. PubMed ID: 11068522
    [No Abstract]   [Full Text] [Related]  

  • 29. Developments in understanding the physiology and pharmacology of parkinsonism.
    Teräväinen H; Calne DB
    Acta Neurol Scand; 1979 Jul; 60(1):1-11. PubMed ID: 40381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Some aspects of dopamine in the basal ganglia.
    Carlsson A
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():181-9. PubMed ID: 12545
    [No Abstract]   [Full Text] [Related]  

  • 31. [The role of dopamine in the physiology and pathology of the basal ganglia].
    Arushanian EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):595-603. PubMed ID: 4341763
    [No Abstract]   [Full Text] [Related]  

  • 32. Parkinson's disease is a neuropsychiatric disorder.
    Agid Y; Arnulf I; Bejjani P; Bloch F; Bonnet AM; Damier P; Dubois B; François C; Houeto JL; Iacono D; Karachi C; Mesnage V; Messouak O; Vidailhet M; Welter ML; Yelnik J
    Adv Neurol; 2003; 91():365-70. PubMed ID: 12442695
    [No Abstract]   [Full Text] [Related]  

  • 33. Neurotransmitters and their receptors in the basal ganglia.
    McGeer PL; McGeer EG
    Adv Neurol; 1993; 60():93-101. PubMed ID: 8093584
    [No Abstract]   [Full Text] [Related]  

  • 34. [Neuraminergic conception of extrapyramidal syndromology].
    Levin SL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(2):293-9. PubMed ID: 139066
    [No Abstract]   [Full Text] [Related]  

  • 35. Ultrastructural chemoanatomy of the basal ganglia: an overview.
    Pasik P; Pasik T; Holstein GR
    Adv Neurol; 1987; 45():59-66. PubMed ID: 2881451
    [No Abstract]   [Full Text] [Related]  

  • 36. Functional aspects of serotonin transmission in the basal ganglia: a review and an in vivo approach using the push-pull cannula technique.
    Soubrié P; Reisine TD; Glowinski J
    Neuroscience; 1984 Nov; 13(3):605-25. PubMed ID: 6084828
    [No Abstract]   [Full Text] [Related]  

  • 37. Nonmotor functions of the basal ganglia.
    Bodis-Wollner I; Yahr MD; Mylin LH
    Adv Neurol; 1984; 40():289-98. PubMed ID: 6695605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Functions and metabolic rates of transmitters in the basal ganglia].
    Nomoto M; Iwata S
    Nihon Rinsho; 2000 Oct; 58(10):1987-93. PubMed ID: 11068436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effects of lesions in the compact part of the substantia nigra on glutamate and GABA release in the pedunculopontine nucleus].
    Blanco-Lezcano L; Rocha-Arrieta LL; Alvarez-González L; Martínez-Martí L; Pavón-Fuentes N; González-Fraguela ME; Bauzá-Calderín Y; Coro-Grave de Peralta Y
    Rev Neurol; 2005 Jan 1-15; 40(1):23-9. PubMed ID: 15696422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential transmitter release from nerve terminals isolated from basal ganglia and substantia nigra.
    Hardy JA; de Belleroche JS; Border D; Bradford HF
    J Neurochem; 1980 May; 34(5):1130-9. PubMed ID: 6103020
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.